A new treatment for chronic pain conditions such as migraine and neuropathic pain has entered clinical trials. The new med, currently called NGX426, is an AK-receptor antagonist that could become a non-narcotic, non-vascular medication option for people who suffer from chronic pain.
Read moreFull Question: I am getting botox injections for migraines 12/09. This will be my first time with botox injections. I have had a... Read more »
Full Question: Is What pain meds can I use ? FOR STATUS MIGRAINE & STATUS AURA?NSAIDS ARE BANNED DUE TO BLEEDING & CODIENE... Read more »
Full Question: I can't afford my migraine meds-my insurance does not cover. Is there an otc? I have 'lived' with migraines most of my... Read more »
From recent conversations, it seems that there is some confusion about what medications can and cannot abort a Migraine attack. This can be... Read more »
Full Question: How do you balance your depression meds against your migraines?I have been to 5 neurologists for treatment for my migraines.... Read more »
Drugmaker MAP Pharmaceuticals says that their inhaled migraine medication Levadex met all four of the study's goals in a recent clinical trial. The... Read more »
An orally-inhaled migraine medication called Levadex may help ease symptoms, a new Phase III study suggests. The study, funded by the drugmaker,... Read more »
A new medication relieves migraine pain without causing heart problems, according to a recent trial. The experimental medicine could provide a... Read more »
This is a study to evaluate the effects of a new Imitrex/naproxen combo med in migraine patients who don't respond well to Relpax. This national... Read more »
This is a study to evaluate the effects of a combination of Imitrex and naproxen in migraine patients who don't respond to Relpax. This national... Read more »